Bộ Tài chính và Ngân hàng Trung ương Nga có kế hoạch ra mắt Sàn giao dịch tiền điện tử quốc gia

FutureGen

company

About

FutureGen is an research and development manufacturer for antibody medication.

  • 1 - 10

Details

Last Funding Type
Series B
Last Funding Money Raised
¥300M
Industries
Biotechnology,Manufacturing
Founded date
Jan 1, 2014
Number Of Employee
1 - 10
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥300M
FutureGen has raised a total of ¥300M in funding over 2 rounds. Their latest funding was raised on Mar 12, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 12, 2021 Series B ¥300M 2 Zhongjin Qide Detail

Investors

Number of Lead Investors
Number of Investors
1
2
FutureGen is funded by 2 investors. Zhongjin Qide and Lilly Asia Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Zhongjin Qide Yes Series B
Lilly Asia Ventures Series B